Luminex launched the FlexmiR Select miRNA Select assay for the creation of customized RNA panels. Genetix released CloneMedia-HEK and CloneMedia-CHOK1. Millipore announced the “Stem Cell Tested” Initiative to ensure that many of its filter products are validated for use on stem cells, starting with the Stericup with Express PLUS membrane. Millipore launched its Tyrosine Kinases […]
Abeome granted Millipore an exclusive worldwide license to market and distribute the Human Embryonic Stem Cell Antigen-1 antibody for research use. In December 2007, EMD Chemicals’ Novagen brand licensed Luminex’s xMAP Technology platform in order to develop immunoassays for it. Rules-Based Medicine granted EMD Chemicals exclusive distribution rights to its quantitative protein multiplex assays, and […]
Jena, Germany 2/27/08—Laboratory automation supplier CyBio AG announced that it has appointed Dr. Holger Wolf as CEO effective March 1. Mr. Wolf was most recently vice president of Sales, Central Europe, for the Danish medical products firm Coloplast. He joins the company’s executive committee, whose other member is Sonja Strauss.
Under a comarketing alliance, CambridgeSoft will market Off-Label.com’s content via its Database Gateway. Phase Forward established a subsidiary within the facilities of its Indian partner, Virtusa, in Hyderabad, India, in November 2007. The Swiss Institute of Bioinformatics, the University of Geneva’s Proteome Informatics Group and Microsoft Research launched a two-year collaborative project to use MS […]
Paoli, PA 2/26/08—AMETEK has acquired Motion Control Group (MCG), a manufacturer of motors and motion control solutions for a range of markets, including the medical and life sciences markets. MCG generates annual sales of approximately $26 million. “MCG greatly enhances our capability in providing precision motion technology solutions,” stated AMETEK Chairman and CEO Frank S. […]
Sunnyvale, CA 2/5/08 and 2/25/08; Houston, Texas 2/7/08—Publicly held Integrated Media Holdings (IMHI) has acquired TeleChem International for 35 million shares, or approximately 64.4% of the outstanding shares, following a 1 for 30 reverse stock split. TeleChem operates under the name Array It and provides cost-effective microarray systems and products. “The business combination with IMHI […]
Norwalk, CT 2/29/08—Applera has announced its Celera subsidiary, one of the company’s two tracking stocks, along with Applied Biosystems, will pursue a possible spin-off from Applera to become a separately traded public firm (see IBO 8/15/07). Celera provides diagnostic products and services. Holders of the Celera tracking stock would receive Celera shares in a one-for-one […]
Holliston, MA 2/6/08—Harvard Bioscience announced that it has adopted a shareholders rights plan designed to protect the company in the case of a hostile takeover bid. Each stock holder will recive one preferred stock purchase right per share, which will become exercisable in the event of one person’s purchase of, or tender offer for, 20% […]
Gentelligent launched BasePro 1.0, a downloadable, add-in, Excel-based software for handling DNA, RNA and protein data. Advanced Chemistry Development released ACD/Labs 11, featuring updates for many of its products, including ACD/IntelliXtract for LC/MS componentization. Applied Biosystems released GeneMapper ID-X software for the automation of the routine review of forensic DNA data. Timeless Medical Systems released […]
Once again this year, the seasonally strong calendar year 2007 fourth quarter did not disappoint, topping off a year of solid growth for some of the analytical instrument industry’s largest companies. Of the 10 analytical and life science instrument businesses discussed on pages 9–11 that presented quarterly results in US dollars, eight posted double-digit revenue […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
